54
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

, , , , , & show all
Pages 381-390 | Published online: 25 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Konstantinos Kostikas, Alexander J Mackay, Claus F Vogelmeier, Stefan-Marian Frent, Pritam Gupta, Donald Banerji, Francesco Patalano, Pascal J Pfister & Jadwiga A Wedzicha. (2020) Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1831-1838.
Read now
Konstantinos Kostikas, Maryam Aalamian-Mattheis, Veronica Anna Pagano, Xavier Nunez, Robert Fogel, Francesco Patalano & Andreas Clemens. (2018) Early Changes in eDiary COPD Symptoms Predict Clinically Relevant Treatment Response at 12 Weeks: Analysis from the CRYSTAL Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:2, pages 185-191.
Read now
Donald P Tashkin & Charlie Strange. (2018) Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2587-2601.
Read now
Liwei Cui, Xiuli Ji, Mengshuang Xie, Shuang Dou, Wei Wang & Wei Xiao. (2017) Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2823-2830.
Read now